Salivary Cytokines, MMP-8 and Dental Caries in Osteoporosis Patients
- Sponsor
- Afyonkarahisar Health Sciences University
- Study ID
- NCT07709247
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Biomarkers
- Dental Caries
- Matrix Metalloproteinase 8
- Osteoporosis
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 75 Years
- Healthy Volunteers
- Accepted
Study Details
This study examines saliva samples from patients with osteoporosis. The levels of cytokines and Matrix Metalloproteinase-8 (MMP-8) enzyme in saliva will be measured. Additionally, the dental caries status of participants will be evaluated. The aim of this study is to understand the relationship between osteoporosis and oral health. Only saliva samples will be collected from participants; no treatment or medication will be administered.
Key Dates
- First listed
- Jul 16, 2026
- Start date
- Jul 10, 2026
- Status verified
- Jul 2026
- Primary completion
- Sep 30, 2026
- Completion
- Jul 10, 2027
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: Osteoporosis GroupPatients diagnosed with osteoporosis. Saliva samples will be collected to measure cytokine levels and MMP-8.
- Arm: Control GroupHealthy individuals without osteoporosis. Saliva samples will be collected for comparison.
Primary Outcome Measure
Salivary Cytokine Levels [ Time Frame: day 1 ]
Central Contacts
- Kübra Karaçam, Asist.Prof.+905059396258
Related Studies
- Mode of Exercise and Bone Biomarkers in Older VeteransRecruiting · VA Office of Research and Development · Aurora, Colorado
- Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity ArthroplastyRecruiting · Johns Hopkins University · Columbia, Maryland
- Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized PatientsRecruiting · University of Chicago · Chicago, Illinois
- Effect of Acetylcholinesterase Inhibitors on Bone MetabolismPHASE2 · Recruiting · Duke University · Durham, North Carolina